nefopam has been researched along with ondansetron in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Alfonsi, P | 1 |
| Coppé, MC; Gillardin, JM; Girard, P; Niedergang, B; Pansart, Y | 1 |
| Chen, J; Chen, Y; Li, MG; Lu, KZ; Shen, H; Tian, GP | 1 |
| Bae, HB; Choi, JI; Kim, JM; Kim, WM; Lee, HG | 1 |
1 review(s) available for nefopam and ondansetron
| Article | Year |
|---|---|
Postanaesthetic shivering: epidemiology, pathophysiology, and approaches to prevention and management.
Topics: Adrenergic alpha-Agonists; Analgesics, Non-Narcotic; Analgesics, Opioid; Anesthesia, General; Hot Temperature; Humans; Hypothermia; Incidence; Ketanserin; Narcotics; Nefopam; Ondansetron; Serotonin Antagonists; Shivering; Tramadol | 2001 |
1 trial(s) available for nefopam and ondansetron
| Article | Year |
|---|---|
Ondansetron does not attenuate the analgesic efficacy of nefopam.
Topics: Adult; Aged; Analgesics; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Nefopam; Ondansetron; Pain Management; Pain, Postoperative; Prospective Studies | 2013 |
5 other study(ies) available for nefopam and ondansetron
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Modulation of paracetamol and nefopam antinociception by serotonin 5-HT(3) receptor antagonists in mice.
Topics: Acetaminophen; Acetic Acid; Analgesics; Animals; Drug Interactions; Indoles; Male; Mice; Mice, Inbred Strains; Nefopam; Ondansetron; Pain Measurement; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Tropisetron | 2009 |
Intrathecal nefopam-induced antinociception through activation of descending serotonergic projections involving spinal 5-HT7 but not 5-HT3 receptors.
Topics: Analgesics; Animals; Injections, Spinal; Male; Nefopam; Ondansetron; Pain; Phenols; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Spinal Cord; Sulfonamides | 2015 |